News

Technology News

Ophthotech Readies Fovista Launch With New Hire

Monday, October 6, 2014 5:00:00 AM PDT | VentureDeal
   New York, New York  --  Biopharmaceutical technology company Ophthotech (NASDAQ: OPHT) has announced the hiring of Todd Smith for the position of Senior Vice President and Chief Commercial Officer.

Mr. Smith will develop and implement the company's commercial strategy through marketing, product access and sales teams.

Ophthotech is preparing to launch its first product, a treatment for age-related macular degeneration called Fovista.

As part of the compensation package, the company is granting Mr. Smith a non-statutory stock option to purchase 150,000 shares of the company's common stock.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1